These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
441 related items for PubMed ID: 23937449
1. Off-label and unlicensed drug use among neonatal intensive care units in Southern Italy. Laforgia N, Nuccio MM, Schettini F, Dell'Aera M, Gasbarro AR, Dell'Erba A, Solarino B. Pediatr Int; 2014 Feb; 56(1):57-9. PubMed ID: 23937449 [Abstract] [Full Text] [Related]
2. Unlicensed and off-label use of medicines at a neonatology clinic in Italy. Dell'Aera M, Gasbarro AR, Padovano M, Laforgia N, Capodiferro D, Solarino B, Quaranta R, Dell'Erba AS. Pharm World Sci; 2007 Aug; 29(4):361-7. PubMed ID: 17351821 [Abstract] [Full Text] [Related]
3. Unlicensed and Off-Label Medication Use in Pediatric and Neonatal Intensive Care Units: No Change Over a Decade. Nir-Neuman H, Abu-Kishk I, Toledano M, Heyman E, Ziv-Baran T, Berkovitch M. Adv Ther; 2018 Jul; 35(7):1122-1132. PubMed ID: 29949042 [Abstract] [Full Text] [Related]
4. Unlicensed and off-label drug use in an Irish neonatal intensive care unit: a prospective cohort study. Kieran EA, O'Callaghan N, O'Donnell CP. Acta Paediatr; 2014 Apr; 103(4):e139-42. PubMed ID: 24397831 [Abstract] [Full Text] [Related]
5. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature. Lindell-Osuagwu L, Korhonen MJ, Saano S, Helin-Tanninen M, Naaranlahti T, Kokki H. J Clin Pharm Ther; 2009 Jun; 34(3):277-87. PubMed ID: 19650250 [Abstract] [Full Text] [Related]
6. Off-label and unlicensed use of medicinal products in the neonatal setting in the Slovak Republic. Schweigertova J, Durisova A, Dolnikova D, Ondriasova E, Balazova M, Slezakova V, Kuzelova M. Pediatr Int; 2016 Feb; 58(2):126-31. PubMed ID: 26256925 [Abstract] [Full Text] [Related]
7. Off-label and unlicensed drug treatments in Neonatal Intensive Care Units: an Italian multicentre study. Cuzzolin L, Agostino R. Eur J Clin Pharmacol; 2016 Jan; 72(1):117-23. PubMed ID: 26490354 [Abstract] [Full Text] [Related]
8. Off-label and unlicensed drug use in neonatal intensive care units in Turkey: the old-inn study. Oguz SS, Kanmaz HG, Dilmen U. Int J Clin Pharm; 2012 Feb; 34(1):136-41. PubMed ID: 22234653 [Abstract] [Full Text] [Related]
9. Off-label and unlicensed drug use in hospitalized newborns in a Saudi tertiary care hospital: a cohort study. Mazhar F, Akram S, Haider N, Hadi MA, Sultana J. Int J Clin Pharm; 2018 Jun; 40(3):700-703. PubMed ID: 29721741 [Abstract] [Full Text] [Related]
10. Unlicensed and off-label drug use in an Australian neonatal intensive care unit. O'Donnell CP, Stone RJ, Morley CJ. Pediatrics; 2002 Nov; 110(5):e52. PubMed ID: 12415058 [Abstract] [Full Text] [Related]
11. Off-label use and harmful potential of drugs in a NICU in Brazil: A descriptive study. de Souza AS, Dos Santos DB, Rey LC, Medeiros MG, Vieira MG, Coelho HLL. BMC Pediatr; 2016 Jan 21; 16():13. PubMed ID: 26795213 [Abstract] [Full Text] [Related]
12. Pattern and extent of off-label and unlicensed drug use in neonatal intensive care units in Iran. Kouti L, Aletayeb M, Aletayeb SMH, Hardani AK, Eslami K. BMC Pediatr; 2019 Jan 04; 19(1):3. PubMed ID: 30609923 [Abstract] [Full Text] [Related]
13. Unlicensed and off-label drug use in children: implications for safety. Choonara I, Conroy S. Drug Saf; 2002 Jan 04; 25(1):1-5. PubMed ID: 11820908 [Abstract] [Full Text] [Related]
14. Off-label and unlicensed drug use in Ayder comprehensive specialized hospital neonatal intensive care unit. Gidey MT, Gebretsadkan YG, Tsadik AG, Welie AG, Assefa BT. Ital J Pediatr; 2020 Apr 03; 46(1):41. PubMed ID: 32245504 [Abstract] [Full Text] [Related]
15. Unlicensed and off-label medication use in a neonatal intensive care unit: a prospective study. Barr J, Brenner-Zada G, Heiman E, Pareth G, Bulkowstein M, Greenberg R, Berkovitch M. Am J Perinatol; 2002 Feb 03; 19(2):67-72. PubMed ID: 11938479 [Abstract] [Full Text] [Related]
16. Risk factors for unlicensed and off-label drug use in children outside the hospital. Schirm E, Tobi H, de Jong-van den Berg LT. Pediatrics; 2003 Feb 03; 111(2):291-5. PubMed ID: 12563053 [Abstract] [Full Text] [Related]
17. Off-label and unlicensed drug use in a Spanish Neonatal Intensive Care Unit. Arocas Casañ V, Cabezuelo Escribano B, Garrido-Corro B, De la Cruz Murie P, Blázquez Álvarez MJ, De la Rubia Nieto MªA. Farm Hosp; 2017 May 01; 41(3):371-381. PubMed ID: 28478751 [Abstract] [Full Text] [Related]
18. Off-label and unlicensed drug use in children admitted to Pediatric Intensive Care Units (PICU). Jobanputra N, Save SU, Bavdekar SB. Int J Risk Saf Med; 2015 May 01; 27(3):113-21. PubMed ID: 26410245 [Abstract] [Full Text] [Related]
19. Unlicensed and off-label use of medicines in children admitted to the intensive care units of a hospital in Malaysia. Lee JL, Redzuan AM, Shah NM. Int J Clin Pharm; 2013 Dec 01; 35(6):1025-9. PubMed ID: 24022725 [Abstract] [Full Text] [Related]
20. Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study. Pratico AD, Longo L, Mansueto S, Gozzo L, Barberi I, Tiralongo V, Salvo V, Falsaperla R, Vitaliti G, La Rosa M, Leonardi S, Rotondo A, Avola N, Sgarlata D, Damiano A, Tirantello M, Anzelmo G, Cipolla D, Rizzo A, Russo A, Ruggieri M, Salomone S, Drago F. Curr Drug Saf; 2018 Dec 01; 13(3):200-207. PubMed ID: 29921210 [Abstract] [Full Text] [Related] Page: [Next] [New Search]